Latest Insider Transactions at Galectin Therapeutics Inc (GALT)
This section provides a real-time view of insider transactions for Galectin Therapeutics Inc (GALT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GALECTIN THERAPEUTICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GALECTIN THERAPEUTICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
15,086
+2.16%
|
$15,086
$1.16 P/Share
|
|
Nov 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,780
+2.02%
|
$13,780
$1.27 P/Share
|
|
Nov 17
2022
|
Jack W Callicutt Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
4,000
+34.44%
|
$4,000
$1.32 P/Share
|
|
Nov 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
14,113
+2.11%
|
$14,113
$1.24 P/Share
|
|
Oct 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,681
+1.94%
|
$12,681
$1.38 P/Share
|
|
Oct 28
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
10,000
+11.76%
|
$10,000
$1.41 P/Share
|
|
Oct 14
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,802
+1.69%
|
$10,802
$1.62 P/Share
|
|
Sep 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,736
+1.71%
|
$10,736
$1.79 P/Share
|
|
Sep 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,777
+1.59%
|
$9,777
$1.79 P/Share
|
|
Aug 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,211
+1.52%
|
$9,211
$1.9 P/Share
|
|
Aug 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,028
+1.35%
|
$16,056
$2.18 P/Share
|
|
Jul 29
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,606
+1.88%
|
$21,212
$2.26 P/Share
|
|
Jul 28
2022
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
5,000
+14.46%
|
$10,000
$2.5 P/Share
|
|
Jul 22
2022
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.09 P/Share
|
|
Jul 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,606
+1.91%
|
$10,606
$1.65 P/Share
|
|
Jun 30
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,359
+2.44%
|
$13,359
$1.31 P/Share
|
|
Jun 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,780
+2.58%
|
$13,780
$1.29 P/Share
|
|
May 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
13,566
+2.61%
|
$13,566
$1.29 P/Share
|
|
May 19
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+7.14%
|
$5,000
$1.33 P/Share
|
|
May 13
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,868
+2.54%
|
$12,868
$1.36 P/Share
|
|
Apr 29
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,290
+2.3%
|
$11,290
$1.55 P/Share
|
|
Apr 18
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+7.69%
|
$5,000
$1.71 P/Share
|
|
Apr 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,057
+2.1%
|
$10,057
$1.74 P/Share
|
|
Apr 04
2022
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
5,000
+16.9%
|
$5,000
$1.6 P/Share
|
|
Mar 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,870
+2.31%
|
$10,870
$1.61 P/Share
|
|
Mar 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
10,057
+2.2%
|
$10,057
$1.74 P/Share
|
|
Feb 28
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
9,358
+95.54%
|
$9,358
$1.87 P/Share
|
|
Feb 15
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,454
+1.93%
|
$16,908
$2.07 P/Share
|
|
Feb 02
2022
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.1 P/Share
|
|
Jan 31
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
112,263
+21.09%
|
$112,263
$1.93 P/Share
|
|
Jan 24
2022
|
Richard E Uihlein |
BUY
Grant, award, or other acquisition
|
Direct |
17,677
+0.22%
|
$17,677
$1.98 P/Share
|
|
Jan 21
2022
|
Elissa J. Schwartz |
BUY
Open market or private purchase
|
Direct |
1,000
+50.0%
|
$2,000
$2.0 P/Share
|
|
Jan 19
2022
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
5,000
+9.09%
|
$5,000
$1.96 P/Share
|
|
Jan 14
2022
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,251
+2.61%
|
$16,502
$2.02 P/Share
|
|
Jan 14
2022
|
Richard A. Zordani Jr. |
BUY
Open market or private purchase
|
Direct |
5,000
+20.34%
|
$10,000
$2.02 P/Share
|
|
Jan 11
2022
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.1 P/Share
|
|
Dec 31
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
8,052
+2.62%
|
$16,104
$2.07 P/Share
|
|
Dec 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
7,407
+2.48%
|
$14,814
$2.25 P/Share
|
|
Dec 06
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
10,000
+9.55%
|
$20,000
$2.31 P/Share
|
|
Dec 02
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$20,000
$2.37 P/Share
|
|
Nov 30
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
6,337
+2.18%
|
$12,674
$2.63 P/Share
|
|
Nov 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,828
+2.05%
|
$11,656
$2.86 P/Share
|
|
Nov 01
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.19 P/Share
|
|
Oct 29
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
5,258
+1.9%
|
$15,774
$3.17 P/Share
|
|
Oct 29
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
2,000
+4.76%
|
$6,000
$3.17 P/Share
|
|
Oct 21
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
2,000
+5.0%
|
$6,000
$3.19 P/Share
|
|
Oct 19
2021
|
Kevin D Freeman |
BUY
Open market or private purchase
|
Indirect |
3,000
+7.69%
|
$9,000
$3.37 P/Share
|
|
Oct 15
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.37 P/Share
|
|
Oct 15
2021
|
Joel Lewis President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
4,946
+1.82%
|
$14,838
$3.37 P/Share
|
|
Oct 04
2021
|
10 X Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,000
-0.16%
|
$30,000
$3.62 P/Share
|